US · Healthcare

Senti Biosciences Inc (SNTI)

Biotechnology

Senti Biosciences Inc (SNTI) is listed on US in the Healthcare sector. Industry: Biotechnology. As of 2026-03-24, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Download on the App Store Get it on Google Play

Key metrics for SNTI

P/E ratio

18.00

Senti Biosciences Inc (SNTI) — FAQ

What is SNTI's P/E ratio?

The price-to-earnings (P/E) ratio for Senti Biosciences Inc (SNTI) is 18.00 (data as of 2026-03-24).

Does Senti Biosciences Inc pay a dividend?

Dividend yield is not available in the current snapshot for Senti Biosciences Inc (SNTI). Check the MyAverix Finance app for the latest dividend data.

What sector is Senti Biosciences Inc in?

Senti Biosciences Inc (SNTI) is classified in the Healthcare sector (Biotechnology industry).

What exchange is SNTI listed on?

SNTI is listed on US.

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

Abbott Laboratories (ABT) AbbVie Inc. CDR (ABBV) Agilent Technologies Inc. (A1GI34) Aimed Bio (0009K0) Alnylam Pharmaceuticals, Inc. (A1LN34) Alvotech (ALVO) Amgen Inc (AMGN34) argenx SE (A1RG34)